BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28038953)

  • 1. Leucine zipper-mediated targeting of multi-enzyme cascade reactions to inclusion bodies in Escherichia coli for enhanced production of 1-butanol.
    Han GH; Seong W; Fu Y; Yoon PK; Kim SK; Yeom SJ; Lee DH; Lee SG
    Metab Eng; 2017 Mar; 40():41-49. PubMed ID: 28038953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of Escherichia coli for 1-butanol production.
    Atsumi S; Cann AF; Connor MR; Shen CR; Smith KM; Brynildsen MP; Chou KJ; Hanai T; Liao JC
    Metab Eng; 2008 Nov; 10(6):305-11. PubMed ID: 17942358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved n-butanol tolerance in Escherichia coli by controlling membrane related functions.
    Bui le M; Lee JY; Geraldi A; Rahman Z; Lee JH; Kim SC
    J Biotechnol; 2015 Jun; 204():33-44. PubMed ID: 25858152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled localization of functionally active proteins to inclusion bodies using leucine zippers.
    Choi SL; Lee SJ; Yeom SJ; Kim HJ; Rhee YH; Jung HC; Lee SG
    PLoS One; 2014; 9(6):e97093. PubMed ID: 24897378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved n-butanol production via co-expression of membrane-targeted tilapia metallothionein and the clostridial metabolic pathway in Escherichia coli.
    Chin WC; Lin KH; Liu CC; Tsuge K; Huang CC
    BMC Biotechnol; 2017 Apr; 17(1):36. PubMed ID: 28399854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Employing bacterial microcompartment technology to engineer a shell-free enzyme-aggregate for enhanced 1,2-propanediol production in Escherichia coli.
    Lee MJ; Brown IR; Juodeikis R; Frank S; Warren MJ
    Metab Eng; 2016 Jul; 36():48-56. PubMed ID: 26969252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-Butylamine production from glucose using a transaminase-mediated synthetic pathway in Escherichia coli.
    Matsumoto T; Mori Y; Tanaka T; Kondo A
    J Biosci Bioeng; 2020 Jan; 129(1):99-103. PubMed ID: 31320263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli.
    Kim SK; Seong W; Han GH; Lee DH; Lee SG
    Microb Cell Fact; 2017 Nov; 16(1):188. PubMed ID: 29100516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional feedback regulation of efflux protein expression for increased tolerance to and production of n-butanol.
    Boyarskiy S; Davis López S; Kong N; Tullman-Ercek D
    Metab Eng; 2016 Jan; 33():130-137. PubMed ID: 26656942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-free framework for rapid biosynthetic pathway prototyping and enzyme discovery.
    Karim AS; Jewett MC
    Metab Eng; 2016 Jul; 36():116-126. PubMed ID: 26996382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted optimization of central carbon metabolism for engineering succinate production in Escherichia coli.
    Zhao Y; Wang CS; Li FF; Liu ZN; Zhao GR
    BMC Biotechnol; 2016 Jun; 16(1):52. PubMed ID: 27342774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways.
    Shen CR; Liao JC
    Metab Eng; 2008 Nov; 10(6):312-20. PubMed ID: 18775501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic engineering of cofactor flavin adenine dinucleotide (FAD) synthesis and regeneration in Escherichia coli for production of α-keto acids.
    Hou Y; Hossain GS; Li J; Shin HD; Du G; Chen J; Liu L
    Biotechnol Bioeng; 2017 Sep; 114(9):1928-1936. PubMed ID: 28498544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous biosynthesis and manipulation of alkanes in Escherichia coli.
    Cao YX; Xiao WH; Zhang JL; Xie ZX; Ding MZ; Yuan YJ
    Metab Eng; 2016 Nov; 38():19-28. PubMed ID: 27267408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotin-independent strains of Escherichia coli for enhanced streptavidin production.
    Jeschek M; Bahls MO; Schneider V; Marlière P; Ward TR; Panke S
    Metab Eng; 2017 Mar; 40():33-40. PubMed ID: 28062280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial organization of heterologous metabolic system in vivo based on TALE.
    Zhu LY; Qiu XY; Zhu LY; Wu XM; Zhang Y; Zhu QH; Fan DY; Zhu CS; Zhang DY
    Sci Rep; 2016 May; 6():26065. PubMed ID: 27184291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.
    Kim SK; Han GH; Seong W; Kim H; Kim SW; Lee DH; Lee SG
    Metab Eng; 2016 Nov; 38():228-240. PubMed ID: 27569599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic engineering of TCA cycle for optimal production of a four-carbon platform chemical 4-hydroxybutyric acid in Escherichia coli.
    Choi S; Kim HU; Kim TY; Lee SY
    Metab Eng; 2016 Nov; 38():264-273. PubMed ID: 27663752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Butanol Production Using FASII Pathway in
    Jawed K; Abdelaal AS; Koffas MAG; Yazdani SS
    ACS Synth Biol; 2020 Sep; 9(9):2390-2398. PubMed ID: 32813973
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.
    Roca-Pinilla R; Fortuna S; Natalello A; Sánchez-Chardi A; Ami D; Arís A; Garcia-Fruitós E
    Microb Cell Fact; 2020 Sep; 19(1):175. PubMed ID: 32887587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.